2026/2027
CPJE Exam (California Pharmacy
Jurisprudence Exam) New 2026/2027
Comprehensive Study Guide for
Licensing Exam Prep, Practice
Questions, Legal Review, and Test
Bank Success
Question 1:
A licensed pharmacist working in a community pharmacy is observed diverting
controlled substances for personal use while appearing visibly impaired during a shift.
According to California pharmacy law, which agency must be contacted to report this
incident?
A. Drug Enforcement Administration (DEA)
B. California Department of Public Health
C. California State Board of Pharmacy
D. Local law enforcement only
Correct Answer: C. California State Board of Pharmacy
Rationale:
The California State Board of Pharmacy is the regulatory agency responsible for
overseeing pharmacists, pharmacy technicians, and pharmacy operations within
California. When a pharmacist or licensed employee is suspected of stealing
medication or working while impaired by controlled substances, the pharmacy is
legally required to report the matter to the Board to protect public safety. While the
DEA may become involved if controlled substances are diverted, the Board is the
primary state authority responsible for disciplinary and licensing action. Local law
enforcement may also investigate criminal activity, but reporting solely to law
enforcement does not satisfy the Board reporting requirement. The Department of
Public Health is not the primary agency responsible for pharmacy licensure
enforcement.
Question 2:
A pharmacist is found to be under the influence of a controlled substance while on
duty in a retail pharmacy. Within what time frame must the pharmacy report the
incident to the California State Board of Pharmacy?
,2026/2027
A. Within 24 hours
B. Within 7 days
C. Within 14 days
D. Within 30 days
Correct Answer: C. Within 14 days
Rationale:
California law requires pharmacies to notify the California State Board of Pharmacy
within 14 days when a licensed employee is found to be impaired by drugs or alcohol
while performing professional duties. This reporting requirement exists to protect
patients and ensure rapid intervention when public safety may be compromised.
Reporting within 24 hours is not mandated by law in this circumstance, although
facilities may internally escalate concerns immediately. Waiting 30 days would
violate state reporting regulations. The Board uses these reports to determine whether
disciplinary action, rehabilitation monitoring, or license suspension is necessary.
Question 3:
A pharmacy technician is caught stealing atorvastatin tablets from the pharmacy
inventory. What is the required reporting timeline to the California State Board of
Pharmacy?
A. Immediately upon discovery
B. Within 14 days
C. Within 21 days
D. Within 30 days
Correct Answer: B. Within 14 days
Rationale:
The California State Board of Pharmacy must be notified within 14 days when theft
involving a licensed pharmacy employee occurs. Even though atorvastatin is not a
controlled substance, theft of prescription medication by pharmacy personnel raises
serious concerns regarding professional conduct and patient safety. Immediate
internal action may occur, but the legal reporting timeframe is 14 days. Delaying
notification beyond this period may result in regulatory penalties against the
pharmacy. Reporting helps ensure that potentially dangerous or unethical employees
are investigated appropriately.
Question 4:
A shipment containing dangerous drugs arrives at a pharmacy after business hours
when no pharmacist is physically present. Under California law, under which
circumstance may the facility legally accept the delivery?
A. Deliveries are prohibited when no pharmacist is present
B. Only if a pharmacy technician signs for the delivery
,2026/2027
C. If there is secure storage within the same building as the pharmacy
D. Only controlled substances may be accepted after hours
Correct Answer: C. If there is secure storage within the same building as the
pharmacy
Rationale:
California law permits delivery of dangerous drugs and devices when no pharmacist is
on duty only if the drugs are placed into a secure storage area located within the same
building as the pharmacy. This rule helps maintain drug security and chain of custody
while allowing operational flexibility for deliveries. A technician alone cannot
override this requirement unless the storage conditions comply with legal standards.
Deliveries are not universally prohibited after hours, and the rule applies broadly to
dangerous drugs and devices, not exclusively controlled substances.
Question 5:
A pharmacist notices that the font size on a prescription container label is extremely
small and difficult for an elderly patient to read. Legally, this issue may constitute
which of the following?
A. Drug adulteration
B. Misbranding
C. Therapeutic duplication
D. Off-label dispensing
Correct Answer: B. Misbranding
Rationale:
Prescription labels must be legible and understandable to patients. If the font size is
too small to reasonably read, the medication may be considered misbranded under
pharmacy and FDA labeling standards. Misbranding occurs when labeling fails to
provide adequate directions or information necessary for safe use. Adulteration refers
to contamination or compromised product quality rather than labeling issues.
Therapeutic duplication involves multiple medications from the same therapeutic
class, while off-label dispensing refers to use outside FDA-approved indications.
Proper labeling is essential for patient safety and medication adherence.
Question 6:
True or False: If the label on a prescription bottle is too small for a patient to read, the
prescription is considered misbranded.
A. True
B. False
C. Only if the patient complains
D. Only for controlled substances
, 2026/2027
Correct Answer: A. True
Rationale:
A prescription label that is unreadable due to excessively small font size may legally
constitute misbranding because patients cannot safely access the required medication
information. Pharmacy law emphasizes readability as a component of adequate
labeling. This applies regardless of whether the patient complains or whether the
medication is controlled. Readable instructions are necessary to ensure proper
medication use and prevent errors such as incorrect dosing or administration.
Question 7:
A manufacturer changes the color of an antihypertensive tablet from blue to pink
without affecting potency or therapeutic effect. The product is later recalled because
of the appearance change. Which class of recall best describes this situation?
A. Class I recall
B. Class II recall
C. Class III recall
D. Market withdrawal
Correct Answer: C. Class III recall
Rationale:
A Class III recall involves products that are unlikely to cause adverse health
consequences but violate FDA labeling or manufacturing standards. In this case, the
color change could confuse patients but does not directly compromise safety or
effectiveness. Class I recalls involve serious risks that could lead to severe injury or
death, while Class II recalls involve temporary or medically reversible adverse effects.
A market withdrawal generally addresses minor issues not subject to formal FDA
recall classification.
Question 8:
A medication is recalled because use of the product may cause temporary or
medically reversible adverse health consequences. What type of recall is this?
A. Class I recall
B. Class II recall
C. Class III recall
D. Voluntary withdrawal
Correct Answer: B. Class II recall
Rationale:
A Class II recall applies when exposure to a defective product may cause temporary
or medically reversible adverse health effects, or when the probability of serious harm
is remote. These recalls are serious but not immediately life-threatening. Class I
CPJE Exam (California Pharmacy
Jurisprudence Exam) New 2026/2027
Comprehensive Study Guide for
Licensing Exam Prep, Practice
Questions, Legal Review, and Test
Bank Success
Question 1:
A licensed pharmacist working in a community pharmacy is observed diverting
controlled substances for personal use while appearing visibly impaired during a shift.
According to California pharmacy law, which agency must be contacted to report this
incident?
A. Drug Enforcement Administration (DEA)
B. California Department of Public Health
C. California State Board of Pharmacy
D. Local law enforcement only
Correct Answer: C. California State Board of Pharmacy
Rationale:
The California State Board of Pharmacy is the regulatory agency responsible for
overseeing pharmacists, pharmacy technicians, and pharmacy operations within
California. When a pharmacist or licensed employee is suspected of stealing
medication or working while impaired by controlled substances, the pharmacy is
legally required to report the matter to the Board to protect public safety. While the
DEA may become involved if controlled substances are diverted, the Board is the
primary state authority responsible for disciplinary and licensing action. Local law
enforcement may also investigate criminal activity, but reporting solely to law
enforcement does not satisfy the Board reporting requirement. The Department of
Public Health is not the primary agency responsible for pharmacy licensure
enforcement.
Question 2:
A pharmacist is found to be under the influence of a controlled substance while on
duty in a retail pharmacy. Within what time frame must the pharmacy report the
incident to the California State Board of Pharmacy?
,2026/2027
A. Within 24 hours
B. Within 7 days
C. Within 14 days
D. Within 30 days
Correct Answer: C. Within 14 days
Rationale:
California law requires pharmacies to notify the California State Board of Pharmacy
within 14 days when a licensed employee is found to be impaired by drugs or alcohol
while performing professional duties. This reporting requirement exists to protect
patients and ensure rapid intervention when public safety may be compromised.
Reporting within 24 hours is not mandated by law in this circumstance, although
facilities may internally escalate concerns immediately. Waiting 30 days would
violate state reporting regulations. The Board uses these reports to determine whether
disciplinary action, rehabilitation monitoring, or license suspension is necessary.
Question 3:
A pharmacy technician is caught stealing atorvastatin tablets from the pharmacy
inventory. What is the required reporting timeline to the California State Board of
Pharmacy?
A. Immediately upon discovery
B. Within 14 days
C. Within 21 days
D. Within 30 days
Correct Answer: B. Within 14 days
Rationale:
The California State Board of Pharmacy must be notified within 14 days when theft
involving a licensed pharmacy employee occurs. Even though atorvastatin is not a
controlled substance, theft of prescription medication by pharmacy personnel raises
serious concerns regarding professional conduct and patient safety. Immediate
internal action may occur, but the legal reporting timeframe is 14 days. Delaying
notification beyond this period may result in regulatory penalties against the
pharmacy. Reporting helps ensure that potentially dangerous or unethical employees
are investigated appropriately.
Question 4:
A shipment containing dangerous drugs arrives at a pharmacy after business hours
when no pharmacist is physically present. Under California law, under which
circumstance may the facility legally accept the delivery?
A. Deliveries are prohibited when no pharmacist is present
B. Only if a pharmacy technician signs for the delivery
,2026/2027
C. If there is secure storage within the same building as the pharmacy
D. Only controlled substances may be accepted after hours
Correct Answer: C. If there is secure storage within the same building as the
pharmacy
Rationale:
California law permits delivery of dangerous drugs and devices when no pharmacist is
on duty only if the drugs are placed into a secure storage area located within the same
building as the pharmacy. This rule helps maintain drug security and chain of custody
while allowing operational flexibility for deliveries. A technician alone cannot
override this requirement unless the storage conditions comply with legal standards.
Deliveries are not universally prohibited after hours, and the rule applies broadly to
dangerous drugs and devices, not exclusively controlled substances.
Question 5:
A pharmacist notices that the font size on a prescription container label is extremely
small and difficult for an elderly patient to read. Legally, this issue may constitute
which of the following?
A. Drug adulteration
B. Misbranding
C. Therapeutic duplication
D. Off-label dispensing
Correct Answer: B. Misbranding
Rationale:
Prescription labels must be legible and understandable to patients. If the font size is
too small to reasonably read, the medication may be considered misbranded under
pharmacy and FDA labeling standards. Misbranding occurs when labeling fails to
provide adequate directions or information necessary for safe use. Adulteration refers
to contamination or compromised product quality rather than labeling issues.
Therapeutic duplication involves multiple medications from the same therapeutic
class, while off-label dispensing refers to use outside FDA-approved indications.
Proper labeling is essential for patient safety and medication adherence.
Question 6:
True or False: If the label on a prescription bottle is too small for a patient to read, the
prescription is considered misbranded.
A. True
B. False
C. Only if the patient complains
D. Only for controlled substances
, 2026/2027
Correct Answer: A. True
Rationale:
A prescription label that is unreadable due to excessively small font size may legally
constitute misbranding because patients cannot safely access the required medication
information. Pharmacy law emphasizes readability as a component of adequate
labeling. This applies regardless of whether the patient complains or whether the
medication is controlled. Readable instructions are necessary to ensure proper
medication use and prevent errors such as incorrect dosing or administration.
Question 7:
A manufacturer changes the color of an antihypertensive tablet from blue to pink
without affecting potency or therapeutic effect. The product is later recalled because
of the appearance change. Which class of recall best describes this situation?
A. Class I recall
B. Class II recall
C. Class III recall
D. Market withdrawal
Correct Answer: C. Class III recall
Rationale:
A Class III recall involves products that are unlikely to cause adverse health
consequences but violate FDA labeling or manufacturing standards. In this case, the
color change could confuse patients but does not directly compromise safety or
effectiveness. Class I recalls involve serious risks that could lead to severe injury or
death, while Class II recalls involve temporary or medically reversible adverse effects.
A market withdrawal generally addresses minor issues not subject to formal FDA
recall classification.
Question 8:
A medication is recalled because use of the product may cause temporary or
medically reversible adverse health consequences. What type of recall is this?
A. Class I recall
B. Class II recall
C. Class III recall
D. Voluntary withdrawal
Correct Answer: B. Class II recall
Rationale:
A Class II recall applies when exposure to a defective product may cause temporary
or medically reversible adverse health effects, or when the probability of serious harm
is remote. These recalls are serious but not immediately life-threatening. Class I
